UNandUP Co-Founder Peter Finley to Speak on Cybersecurity Panel at LSI USA 2026

We are delighted to share that our Co-founder, Peter Finley, will serve as a panelist on the Cybersecurity Panel at LSI USA 2026, taking place March 16–20 in Dana Point, California. He will join Jordan John (Blue Goat Cyber) and Gavin Leonard (MedTech Syndicates) to lead the discussions on the competitive advantages of cybersecurity in Life Sciences innovation.

Peter’s passion for med-tech and building transformative solutions led him to co-found UNandUP, where he focuses on funding strategy and venture capital engagement, bringing deep experience across private equity and strategic advisory.

He began his career as a strategy consultant at Marakon Associates and in investment banking at Morgan Stanley. He holds an MBA from Stanford University and earned his undergraduate degree from Princeton University. UNandUP is his third co-founded company, following the cybersecurity firm, Observable Networks and private equity firm, Thompson Street Capital Partners with over $2 billion under management. Peter has completed approximately 35 acquisitions and divestitures in private equity. 

Under his leadership, UNandUP has achieved significant milestones, including:
• Raised $12M in non-dilutive funding since 2019 through NIH SBIR grants and NIH I-Corps, Blueprint, and Breakthrough Technology awards.
• Targeted a large and growing market opportunity, with MeVOs representing a $4B+ U.S. segment and a combined MeVO and LVO opportunity approaching $7B.
• Expanded clinical scope with a system designed to enable radial-first thrombectomy for medium vessel occlusions, addressing distal anatomy where current large-profile systems often struggle.
• Advanced a novel magnetically enabled over-the-wire catheter architecture, with profiles as small as 1 mm, 3D localization, clot-face and flow sensing, force-controlled navigation, directed agent delivery, and concurrent aspiration.
• Engaged in early partnership discussions with a major C-arm manufacturer to integrate 3D localization and imaging for streamlined navigation visualization, and workflow.
• Conducted an FDA Pre-Sub, completed preclinical prototypes, initiated in vivo animal efficacy studies, identified 510(k) predicates, and established potential eligibility for the FDA Breakthrough Devices Program.
• Built a strong clinical KOL network, including collaborators from Mayo Clinic, UC San Diego, University of Virginia, Washington University in St. Louis, Royal Melbourne Hospital, and UMass Memorial Health.

Connect with Peter Finley onsite at LSI’26 to learn more about UN&UP.